Silica Nanoparticles Cause Activation of NLRP3 Inflammasome in-vitro Model-Using Microglia
Shanshan Hou,Chao Li,Yihua Wang,Jiayin Sun,Yutong Guo,Xiaofan Ning,Kai Ma,Xinyue Li,Hua Shao,Guanqun Cui,Minghua Jin,Zhongjun Du
DOI: https://doi.org/10.2147/IJN.S372485
IF: 7.033
2022-11-11
International Journal of Nanomedicine
Abstract:Shanshan Hou, 1 Chao Li, 2 Yihua Wang, 3 Jiayin Sun, 2 Yutong Guo, 4 Xiaofan Ning, 1 Kai Ma, 1 Xinyue Li, 1 Hua Shao, 2 Guanqun Cui, 5 Minghua Jin, 1 Zhongjun Du 2 1 School of Public Health Jilin University, Changchun, Jilin Province, 130021, the People's Republic of China; 2 Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250062, the People's Republic of China; 3 Chemical Institute of Chemical Industry, Xinjiang University of Science and Technology, Korla, Bayinguoleng Mongolian Autonomous Prefecture, Xinjiang Uygur Autonomous Region, 841000, the People's Republic of China; 4 Navel Medical University, Shanghai, 200433, the People's Republic of China; 5 Department of Respiratory Medicine, Children's Hospital Affiliated to Shandong University, Ji'nan, Shandong Province, 250022, the People's Republic of China Correspondence: Minghua Jin, School of Public Health, Jilin University, Changchun, Jilin Province, 130021, the People's Republic of China, Email Zhongjun Du, Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250062, the People's Republic of China, Email Introduction: Silica nanoparticles (SiNPs) have been widely used in food, cosmetics, medicine and other fields; however, there have been growing concerns regarding their potential adverse effects on health. A large number of studies have confirmed that SiNPs with small particle diameters can pass through the blood brain barrier, causing irreversible damage to the nervous system. This study aims to further explore the molecular mechanism of neurotoxicity of SiNPs and provide a toxicological basis for the medical application of SiNPs. Methods: We conducted an in vitro study using neuroimmune cells (mouse microglial cells, BV2) of the central nervous system to study inflammation and ferroptosis after exposure to SiNPs. We detected cell viability, morphology and ultrastructure, antioxidant function, inflammation, and ferroptosis-related proteins to explore the role of pyroptosis and ferroptosis in the damage of BV2 cells induced by SiNPs. We further explored the relationship between the inflammatory response and ferroptosis induced by SiNPs by silencing the NOD-like receptor thermal protein domain associated protein 3 (NLRP3) gene and inhibiting ferroptosis. Results: The results showed that SiNPs could invade the cytoplasm, change the ultrastructure, activate NLRP3 inflammasomes, release a large number of inflammatory factors, and trigger inflammatory reaction. We also found that SiNPs could disrupt cellular antioxidant function, increase intracellular ferrous ion level and induce ferroptosis. In addition, both inflammation and ferroptosis are alleviated in NLRP3 gene-silenced cells. Conclusion: SiNPs could induce BV2 cytotoxicity through inflammatory response and ferroptosis, which may be mediated by the activation of the NLRP3 inflammasomes. Keywords: SiNPs, microglia, inflammation, ferroptosis, molecular mechanism Silica nanoparticles (SiNPs) have become one of the most well-recognized nanomaterials in human life. A large number of commercial products containing SiNPs have entered the market, as food packaging, cosmetics and electronic products. SiNPs are also widely used in the biomedical field due to their large specific surface area, easy surface modification and superior biocompatibility for various applications, including medical imaging, cancer diagnosis and cell tracking. 1 Especially in the treatment of central nervous system (CNS) diseases, the application of SiNPs has realized the targeted delivery of macromolecular drugs to the brain. 2 The modified SiNPs form colloids to repair the damaged spinal cord and rebuild the CNS. 3 Previous study has reported that the entry of SiNPs into the brain may be possible via several pathways, thus causing neurotoxicity. 4 One of the well-studied modes of entry of SiNPs into the brain is through olfactory sensory neurons (OSNs) and their projections to the olfactory bulb. 5 Another possible mode of entry is through neurons afferent from the trigeminal nerve directly pass through the nasal mucosa and enter the brain stem at the pons level. 6 In addition, in vivo studies have found that small SiNPs can directly crossing the blood-brain barrier and entering the brain, causing irreversible damage to the CNS. 7–9 However, the molecular mechanisms of SiNP -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology